HANNAH JENKINS: Open Payments
NPI 1144972944 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 8 payments from 6 companies in 2025. Trend: 2023 $55 · 2024 $22 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Indivior Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Alkermes, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: ABILIFY ASIMTUFII, SUBLOCADE, CAPLYTA, ARISTADA, UZEDY, Auvelity, REXULTI.
Industry payments across IN — which companies pay providers there.
